A double-blind, placebo-controlled phase Ila study investigating CYT003-QbG10 as a novel immunotherapy in patients suffering from house dust mite allergy gan Kuendig, T, Pichler, C, Scherer, K, Bircher, A, Mueller, P, Ulrich, M, Bachmann, M, Renner, W, Senti, G

Putting appraisal in context gan Parkinson, B

Awduron Eraill: “...Scherer, K...”